Lasalle Investment Management Securities LLC Invests $66.94 Million in Sabra Healthcare REIT, Inc. $SBRA

Lasalle Investment Management Securities LLC bought a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the 4th quarter, HoldingsChannel reports. The fund bought 3,534,217 shares of the real estate investment trust’s stock, valued at approximately $66,938,000. Sabra Healthcare REIT accounts for approximately 2.7% of Lasalle Investment Management Securities LLC’s holdings, making the stock its 16th largest holding.

Other institutional investors and hedge funds have also modified their holdings of the company. Rothschild Investment LLC lifted its position in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares during the last quarter. Founders Capital Management bought a new position in Sabra Healthcare REIT in the third quarter valued at about $28,000. Strengthening Families & Communities LLC bought a new position in shares of Sabra Healthcare REIT during the fourth quarter worth about $29,000. Danske Bank A S bought a new position in shares of Sabra Healthcare REIT during the third quarter worth about $30,000. Finally, Larson Financial Group LLC raised its position in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 553 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $19.89 on Monday. The business has a 50 day simple moving average of $20.29 and a 200 day simple moving average of $19.71. Sabra Healthcare REIT, Inc. has a one year low of $17.13 and a one year high of $21.28. The stock has a market capitalization of $5.02 billion, a P/E ratio of 31.57, a P/E/G ratio of 1.49 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter last year, the firm posted $0.37 earnings per share. The firm’s revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts expect that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.0%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Cantor Fitzgerald raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Weiss Ratings downgraded Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Friday, May 1st. Citizens Jmp raised their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a research report on Wednesday, February 18th. UBS Group raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 13th. Finally, Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, March 26th. Five investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $22.30.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.